Advertisement

Topics

THE ANDA GALLOP

05:32 EST 19 Jan 2019 | PharmaBiz

In spite of several headwinds including intermittent warning letters by the US FDA even to major Indian companies, the Indian pharmaceutical companies and their subsidiaries have shown an impressive performance

Original Article: THE ANDA GALLOP

NEXT ARTICLE

More From BioPortfolio on "THE ANDA GALLOP"

Advertisement
Quick Search
Advertisement
Advertisement